1[18]Cannom D S, Prystowsky E P. Management of ventricular arrhythmias. JAMA, 1999,1 281:1 933
2[19]Inoue S,Yokota Y,Takaoka H et al. Effect of beta-blocker therapy on severe ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Jpn Circ J, 2000,64 (2): 87
3[20]Moss A J,Hall H J,Cannom D S. Improved survival with an implanted defibrillator in patients with coronary disease at high irsk for ventricular arrhythmis: multicenter Automatic Defibrillator Implantation Trial investigators. N Engl J Med, 1996,335 : 1 933
4[21]Buxton A E. Presentation for the MUSTT investigators of the Multicenter unsustained Tachycardia Trial. American College of Cardiology Annual Scientific Session,New Orleans,LA. 1999
5[22]Hmmill S C,Packer D L. Amiodarone in congestive heart failure:unraveling the GESICA and CHF-STAT differences. Birt Heart J,1996,75(1):6
6[23]The Investigators of the Antiarrhythmics versus Implantable defibrillatiors(AViD) Trial. A comparison of antiarrhythmicdrug therapy with implantable defibrillatos in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med, 1997,337:1 576
7[24]Ellison KE,Stevenson WG, Sweeney et al. Catheter ablation for hemodynamically unstable nonomorphic ventricular tachycardia. J Cardiovasc Electrophysiol, 2000,11(1) : 41
9[26]Tchou P,Mehdirad A A. Bundle branch reentry ventricular taehycardia. PACe, 1995,18:1 427
10[27]Rodriquez LM, Smeets J L, timmermans C et al. Predictors of successful ablation of right and left-sided idiopathic ventricular tachycardia. Am J Cardiol,1997,79 :309
